Skip to main content
ScholarsBetaWeill Cornell Medicine

Highlights

  1. 1
    JCI insight · 2021
    SPSallie PermarGFGenevieve Fouda
    PMID: 34228642PMCID: PMC8492306DOISenior author42 citations
  2. 2
    Science advances · 2022
    SPSallie PermarGFGenevieve Fouda
    PMID: 36149967PMCID: PMC9506727DOISenior author17 citations
  3. 3
    The Journal of infectious diseases · 2022
    ANAshley NelsonSPSallie PermarGFGenevieve Fouda
    PMID: 34962990PMCID: PMC9113503DOISenior author11 citations

Publications

106 publications

Funding

19 grantsView NIH portfolio on RePORTER ↗

Active

13 grants
  • MPI
    Evolving bnAb B cell lineages via OMV-displayed multivalent prime-boost strategies in early life for long term HIV protection
    National Institute of Allergy and Infectious Diseases · 2026–2031
    R01AI203537-01
  • KP
    Columbia University-Weill Cornell Medicine CFAR (CU-WCM CFAR)
    National Institute of Allergy and Infectious Diseases · 2026–2031 · via Columbia University
    P30AI191337-01A1
  • KP
    Translating germline-targeting HIV Env SOSIP immunization of infants: targeting bnAbs in early life
    National Institute of Allergy and Infectious Diseases · 2025–2030
    P01AI189362-02
  • PI
    Leveraging novel pediatric SHIVs to identify biomarkers of prophylactic efficacy of bnAb against breast milk HIV transmission
    National Institute of Allergy and Infectious Diseases · 2025–2029
    R01AI184074-01A1
  • MPI
    Advancing Success and Persistence in Research Education (ASPiRE)
    National Institute of General Medical Sciences · 2023–2029Training
    R25GM152362-01
  • Co-I
    Clinical and Translational Science Center - UL1
    National Center for Advancing Translational Sciences · 2022–2027
    UL1TR002384-06
  • MPI
    Clinical and Translational Science Center - TL1
    National Center for Advancing Translational Sciences · 2022–2027
    TL1TR002386-10
  • PI
    Defining and modeling HIV-1-specific antibody function in HIV-1-exposed Infants passively Infused with broadly neutralizing antibodies in the IMPAACT P1112 trial.
    Eunice Kennedy Shriver National Institute of Child Health and Human Development · 2025–2027
    R21HD118592-02
  • Sub-PI
    Impact of Early-life Exposure to Semi-Volatile Organic Compounds (SV)Cs) on Neonatal and Early Childhood Immune Function
    National Institute of Allergy and Infectious Diseases · 2022–2027 · via Duke University
    R01AI167850-05
  • MPI
    Early life B cell responses and inflammation following SARS-CoV-2 infection
    National Institute of Allergy and Infectious Diseases · 2022–2027
    R01AI161008-02
  • Sub-PI
    Sublingual Supromolecular Vaccines and Immunotherapies
    National Institute of Allergy and Infectious Diseases · 2023–2026 · via Duke University
    R01AI167300-04
  • KP
    Pediatric Adolescent Virus Eradiation (PAVE) Martin Delaney Collaboratory
    National Institute of Allergy and Infectious Diseases · 2021–2026 · via The Johns Hopkins University
    UM1AI164566-01
  • Co-I
    Early Life Vaccination to Prevent HIV Acquisition During Adolescence
    National Institute of Allergy and Infectious Diseases · 2021–2026
    P01AI117915-07
Completed grants (6)
  • Sub-PI
    Supramolecular pediatric HIV vaccine design
    National Institute of Allergy and Infectious Diseases · 2022–2025 · via Duke University
    R01AI145016-04
  • PI
    Neutralizing and non-neutralizing antibody effector functions in HIV infected children
    National Institute of Allergy and Infectious Diseases · 2023–2025
    R01AI143370-05
  • KP
    The Origin, Predictors, and Immune Correlates of Viral Rebound in Orally SHIV Infected Infant Monkeys
    National Institute of Allergy and Infectious Diseases · 2021–2023
    P01AI131276-05
  • PI
    Molecular signatures of broad neutralization in HIV infected children
    NICHD · 2020–2022 · via NIH RePORTER
    R21HD102851-01
  • PI
    Functional profile to HIV vaccine elicited antibodies in infants
    NIAID · 2017–2022 · via NIH RePORTER
    R01AI131978-04
  • PI
    Infant immune correlates of perinatal mother to child transmission of HIV
    NICHD · 2015–2017 · via NIH RePORTER
    R03HD085871-02

Clinical research

1 study
Completed & closed trials (1)
  • PI
    Evaluation of biomarkers in children and adolescents exposed to SARS-CoV-2 - BRANYplus Transfer
    Duke University · CLOSED TO ACCRUAL (as of 2024)

News mentions

1 mentionView all WCM news ↗
  • NIH Grant Aims for Childhood Vaccine Against HIV
    September 18, 2025

    A multi-institutional team led by Weill Cornell Medicine investigators has been awarded a five-year, $20.8 million grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, for advanced preclinical development of a promising experimental HIV vaccine.

Mentoring

3 mentees

External relationships

Leadership Roles

THEYA Foundation

Other Interest

Agence nationale de recherches sur le sida et les hépatites virales - maladies infectieuses émergentes (ANRS MIE)